🇵🇱 EUROPEJSKI INSTYTUT BIOMEDYCZNY PL

PCA AB 1763 • Warszawa, 波兰 • 34 项方法

微生物

EUROPEJSKI INSTYTUT BIOMEDYCZNY 是由 PCA 认可的实验室,认可编号 AB 1763(Warszawa,波兰)。认可范围涵盖 34 项检测方法,涉及以下领域:微生物。检测对象包括:医疗器械、Medical devices E。最常用的技术:Gas chromatography method、Gas chromatography with mass spectrometry (GC-MS)、Immunochemical method (ELISA)。

要点速览

  • 认可编号: PCA AB 1763
  • 认可范围内方法数: 34
  • 检测对象种类: 2
  • 所用技术数: 14
  • 城市: Warszawa, 波兰
认可编号
AB 1763
认可机构
PCA
地址
Spółka z ograniczoną odpowiedzialnością, ul. Bartycka 63A lok. 6, 00-716 Warszawa
城市
Warszawa, 波兰

该实验室检测什么 (2)

所用检测技术 (14)

认可范围 — 项检测方法 (34)

序号 检测对象 方法 / 参数 技术 依据文件
检测方法
1 医疗器械 Genotoxicity - AMES PN-EN ISO 10993-3:2014-12
2 医疗器械 Haemolysis Method: - direct - indirect PN-EN ISO 10993-4:2018-02
3 医疗器械 Haemocompatibility – determination of blood coagulation In vitro method PN-EN ISO 10993-4:2018-02
4 医疗器械 Haemocompatibility – platelet activation Immunochemical method (ELISA) PN-EN ISO 10993-4:2018-02
5 医疗器械 Haemocompatibility – determination of haematological blood parameters In vitro method PN-EN ISO 10993-4:2018-02
6 医疗器械 Haemocompatibility – complement system activation Immunochemical method (ELISA) PN-EN ISO 10993-4:2018-02
7 医疗器械 In vitro cytotoxicity Agar diffusion method PN-EN ISO 10993-5:2009
8 医疗器械 In vitro cytotoxicity MEM Elution method PN-EN ISO 10993-5:2009
9 医疗器械 In vitro cytotoxicity MTT method PN-EN ISO 10993-5:2009
10 医疗器械 In vitro irritation PN-EN ISO 10993-23:2021-08
11 医疗器械 In vivo intracutaneous irritant effect PN-EN ISO 10993-23:2021-08
12 医疗器械 In vivo irritant effect PN-EN ISO 10993-23:2021-08
13 医疗器械 In vivo sensitisation - GPMT ISO 10993-10:2021
14 医疗器械 In vivo sensitisation Buehler test ISO 10993-10:2021
15 医疗器械 In vivo sensitisation - LLNA ISO 10993-10:2021
16 医疗器械 In vivo pyrogenic effect PN-EN ISO 10993-11:2018-08
17 医疗器械 Acute toxicity in vivo PN-EN ISO 10993-11:2018-08
18 医疗器械 Subacute toxicity in vivo PN-EN ISO 10993-11:2018-08
19 医疗器械 Subchronic toxicity in vivo PN-EN ISO 10993-11:2018-08
20 医疗器械 Chronic toxicity in vivo PN-EN ISO 10993-11:2018-08
21 医疗器械 In vivo implantation testing PN-EN ISO 10993-6:2017-04
22 医疗器械 Count of aerobic microorganisms (bacteria) on products 膜过滤法 PN-EN ISO 11737 -1:2018-03 | PN-EN ISO 11737 -1:2018-03 / A1:2021-11
23 医疗器械 Sterility of the product Method: direct immersion of the product in the medium PN-EN ISO 11737-2:2020
24 医疗器械 Presence of substances inhibiting the growth of microorganisms, Method suitability test for sterility: bacteriostasis/ fungistasis test PN-EN ISO 11737-2:2020
25 医疗器械 Level of bacterial endotoxins ISO 11737-3:2023
26 医疗器械 Residue after ethylene oxide sterilisation
Ethylene oxide 1.0-60 mg/L Ethylene chlorohydrin 1.0-60 mg/L
Headspace gas chromatography with mass spectrometry (HS-GC-MS) PN-EN ISO 10993-7:2009
27 Medical devices E Identification of extracted / leachable substances:
identification confirmation of the identity of compounds in the mass range 1.2-1100 using mass spectra libraries with the use of a standard Semi-quantitative composition (volatile compounds) HeadSpace with mass spectrometry (HSGC-MS)
Gas chromatography method PN-EN ISO 10993-18:2020-11
28 Medical devices E Identification of extracted / leachable substances:
identification confirmation of the identity of compounds in the mass range 1.2-1100 using mass spectra libraries with the use of a standard Semi-quantitative composition (semi-volatile compounds)
Gas chromatography with mass spectrometry (GC-MS) PN-EN ISO 10993-18:2020-11
29 Medical devices E Identification of extracted / leachable substances:
identification confirmation of the identity of compounds in the mass range 40-3000 using mass spectra libraries with the use of a standard Semi-quantitative composition (non-volatile compounds)
Liquid chromatography with mass spectrometry (LC-MS) PN-EN ISO 10993-18:2020-11
30 医疗器械 Residue after ethylene oxide sterilisation Gas chromatography with a flame ionization detector (GC-FID) PN-EN ISO 10993-7:2009
31 Medical devices E Identification of extracted / leachable substances:
identification confirmation of the identity of compounds in the mass range 1.2-1100 using mass spectra libraries with the use of a standard Semi-quantitative composition (volatile compounds) HeadSpace with mass spectrometry (HSGC-MS)
Gas chromatography method PN-EN ISO 10993-18:2020-11
32 Medical devices E Identification of extracted / leachable substances:
identification confirmation of the identity of compounds in the mass range 1.2-1100 using mass spectra libraries with the use of a standard Semi-quantitative composition (semi-volatile compounds)
Gas chromatography with mass spectrometry (GC-MS) PN-EN ISO 10993-18:2020-11
33 Medical devices E Identification of extracted / leachable substances:
identification confirmation of the identity of compounds in the mass range 40-3000 using mass spectra libraries with the use of a standard Semi-quantitative composition (non-volatile compounds)
Liquid chromatography with mass spectrometry (LC-MS) PN-EN ISO 10993-18:2020-11
34 Medical devices E Analysis of extracted / leachable substances, element concentration 电感耦合等离子体质谱法(ICP-MS) PN-EN ISO 10993-18:2020-11

引用标准 (13)

ISO 10993-10:2021
ISO 11737-3:2023
PN-EN ISO 10993-11:2018-08
PN-EN ISO 10993-18:2020-11
PN-EN ISO 10993-23:2021-08
PN-EN ISO 10993-3:2014-12
PN-EN ISO 10993-4:2018-02
PN-EN ISO 10993-5:2009
PN-EN ISO 10993-6:2017-04
PN-EN ISO 10993-7:2009
PN-EN ISO 11737 -1:2018-03
PN-EN ISO 11737 -1:2018-03 / A1:2021-11
PN-EN ISO 11737-2:2020